Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Interferon beta-1b is a cytokine in the interferon family used to treat the relapsing-remitting and secondary-progressive forms of multiple sclerosis (MS). It is approved for use after the first MS event. Closely related is interferon beta 1a, also indicated for MS, with a very similar drug profile.
Side effects, Efficacy & Commercial formulations
Explore the main themes, entities and connections around Interferon beta-1b. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
interferon ms patients beta-1b beta interferons treatment also relapsing-remitting reactions usually multiple sclerosis related effects therapy skin months symptoms fever
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Interferon beta-1b | AHFS/Drugs.com | Micromedex Detailed Consumer Information | 1.00 | infobox |
| Interferon beta-1b | ATC code | L03AB08 (WHO) | 1.00 | infobox |
| Interferon beta-1b | CAS Number | 145155-23-3 Y | 1.00 | infobox |
| Interferon beta-1b | ChEMBL | ChEMBL1201563 N | 1.00 | infobox |
| Interferon beta-1b | ChemSpider | none | 1.00 | infobox |
| Interferon beta-1b | DrugBank | DB00068 Y | 1.00 | infobox |
| Interferon beta-1b | ECHA InfoCard | 100.207.515 | 1.00 | infobox |
| Interferon beta-1b | Formula | C908H1408N246O253S6 | 1.00 | infobox |
| Interferon beta-1b | IUPHAR/BPS | 8340 | 1.00 | infobox |
| Interferon beta-1b | KEGG | D00746 N | 1.00 | infobox |
| Interferon beta-1b | Legal status | US: ℞-only | 1.00 | infobox |
| Interferon beta-1b | Legal status | EU: Rx-only | 1.00 | infobox |
| Interferon beta-1b | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Interferon beta-1b | License data | EU EMA: by INN | 1.00 | infobox |
| Interferon beta-1b | License data | US DailyMed: Interferon_beta-1b | 1.00 | infobox |
| Interferon beta-1b | MedlinePlus | a601151 | 1.00 | infobox |
| Interferon beta-1b | Molar mass | 20011.08 g·mol−1 | 1.00 | infobox |
| Interferon beta-1b | Routes of administration | Subcutaneous | 1.00 | infobox |
| Interferon beta-1b | Trade names | Betaseron, Actoferon, Extavia | 1.00 | infobox |
| Interferon beta-1b | UNII | TTD90R31WZ | 1.00 | infobox |
| Interferon beta-1b | is a | cytokine in the interferon family used to treat the relapsing-remitting and secondary-progressive forms of multiple sclerosis | 0.90 | text |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.